WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

R RESPIRATORY SYSTEM

Inhaled antiinfectives are classified in ATC group J - Antiinfectives for systemic use.


R05 COUGH AND COLD PREPARATIONS

This group comprises a large number of preparations, most of which are combined preparations.

Cold preparations containing therapeutic levels of antiinfectives should be classified in ATC group J - Antiinfectives for systemic use.

Cold preparations with therapeutic levels of analgesics/anti-inflammatory agents should be classified in the respective N02/M01 groups.

Cold preparations with both antiinfectives and analgesics should be classified in ATC group J - Antiinfectives for systemic use.

Cold preparations with minimal amounts of analgesics are classified in R05X - Other cold preparations.

See also R01 - Nasal preparations, R02 - Throat preparations, and R03D - Other systemic drugs for obstructive airway diseases.

Fixed DDDs are assigned for combinations. These DDDs are based on an average dose regimen of three times daily, and dosages in the upper area of the recommended dose ranges are chosen. The strengths of the various components are not taken into consideration. E.g. 6 UD (= 30 ml) is the fixed DDD for products where the recommended dose is 5-10 ml.


R05D COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS

Combined preparations are classified at separate 5th levels using the code number 20 (R05DA20 and R05DB20). These may also contain bronchodilating agents, antihistamines etc.

Combinations with expectorants, see R05F.

Combinations with xanthines, see R03DA.

Preparations, which contain small amounts of herbal extracts, menthol etc., are not regarded as combined preparations.


R05DB Other cough suppressants

All combined products of other cough suppressants are classified in R05DB20.

Levocloperastine is classified together with cloperastine in R05DB21.


    ATC code  Name  DDD  U Adm.R Note
    R05DB11 pipazetate 80 mg 

List of abbreviations

Last updated: 2018-12-13